Market Research Logo

Isis Pharmaceuticals, Inc. - Product Pipeline Review - 2015

Isis Pharmaceuticals, Inc. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Isis Pharmaceuticals, Inc. - Product Pipeline Review - 2015’, provides an overview of the Isis Pharmaceuticals, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Isis Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Isis Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Isis Pharmaceuticals, Inc.’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Isis Pharmaceuticals, Inc.’s pipeline products
Reasons to buy
  • Evaluate Isis Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Isis Pharmaceuticals, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Isis Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Isis Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Isis Pharmaceuticals, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Isis Pharmaceuticals, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues


Isis Pharmaceuticals, Inc. Snapshot
Isis Pharmaceuticals, Inc. Overview
Key Information
Key Facts
Isis Pharmaceuticals, Inc. - Research and Development Overview
Key Therapeutic Areas
Isis Pharmaceuticals, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Isis Pharmaceuticals, Inc. - Pipeline Products Glance
Isis Pharmaceuticals, Inc. - Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
Isis Pharmaceuticals, Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Isis Pharmaceuticals, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Isis Pharmaceuticals, Inc. - Drug Profiles
ISIS-TTRRx
Product Description
Mechanism of Action
R&D Progress
nusinersen
Product Description
Mechanism of Action
R&D Progress
ISIS-CRPRx
Product Description
Mechanism of Action
R&D Progress
ISIS-EIF4ERx
Product Description
Mechanism of Action
R&D Progress
ISIS-FXIRx
Product Description
Mechanism of Action
R&D Progress
ISIS-GCCRRx
Product Description
Mechanism of Action
R&D Progress
ISIS-GCGRRx
Product Description
Mechanism of Action
R&D Progress
ISIS-PTP1BRx
Product Description
Mechanism of Action
R&D Progress
ISIS-DMPK-2.5
Product Description
Mechanism of Action
R&D Progress
ISIS-APOALRx
Product Description
Mechanism of Action
R&D Progress
ISIS-FGFR4Rx
Product Description
Mechanism of Action
R&D Progress
ISIS-HBVRx
Product Description
Mechanism of Action
R&D Progress
ISIS-PKKRx
Product Description
Mechanism of Action
R&D Progress
Antisense Oligonucleotide to Inhibit C9ORF72 Protein for Amyotrophic Lateral Sclerosis
Product Description
Mechanism of Action
R&D Progress
Antisense Oligonucleotide to Inhibit Cide B for Hyperlipidemia and Atherosclerosis
Product Description
Mechanism of Action
R&D Progress
ISIS-AATRx
Product Description
Mechanism of Action
R&D Progress
ISIS-AGTLRx
Product Description
Mechanism of Action
R&D Progress
ISIS-APOCIIILRx
Product Description
Mechanism of Action
R&D Progress
ISIS-BIIB3Rx
Product Description
Mechanism of Action
R&D Progress
ISIS-DGAT2Rx
Product Description
Mechanism of Action
R&D Progress
ISIS-FVIIRx
Product Description
Mechanism of Action
R&D Progress
ISIS-GHRLRx
Product Description
Mechanism of Action
R&D Progress
ISIS-HTTRx
Product Description
Mechanism of Action
R&D Progress
ISISGSK-4L
Product Description
Mechanism of Action
R&D Progress
ISISGSK-6L
Product Description
Mechanism of Action
R&D Progress
ISISRHO-2.5Rx
Product Description
Mechanism of Action
R&D Progress
Antisense Oligonucleotide 1 for Neurological and Neuromuscular Disorders
Product Description
Mechanism of Action
R&D Progress
Antisense Oligonucleotide 2 for Neurological and Neuromuscular Disorders
Product Description
Mechanism of Action
R&D Progress
Antisense Oligonucleotides to Inhibit BCL11A and KLF1 for Hematological Disorders
Product Description
Mechanism of Action
R&D Progress
Isis Pharmaceuticals, Inc. - Pipeline Analysis
Isis Pharmaceuticals, Inc. - Pipeline Products by Target
Isis Pharmaceuticals, Inc. - Pipeline Products by Route of Administration
Isis Pharmaceuticals, Inc. - Pipeline Products by Molecule Type
Isis Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action
Isis Pharmaceuticals, Inc. - Recent Pipeline Updates
Isis Pharmaceuticals, Inc. - Dormant Projects
Isis Pharmaceuticals, Inc. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
ISIS-104838
ISIS-113715
ISIS-14803
ISIS-2503
ISIS-5132
ISIS-CRPRx
ISIS-EIF4ERx
Isis Pharmaceuticals, Inc. - Company Statement
Isis Pharmaceuticals, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Isis Pharmaceuticals, Inc., Key Information
Isis Pharmaceuticals, Inc., Key Facts
Isis Pharmaceuticals, Inc. - Pipeline by Indication, 2015
Isis Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
Isis Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
Isis Pharmaceuticals, Inc. - Partnered Products in Pipeline, 2015
Isis Pharmaceuticals, Inc. - Partnered Products/ Combination Treatment Modalities, 2015
Isis Pharmaceuticals, Inc. - Out-Licensed Products in Pipeline, 2015
Isis Pharmaceuticals, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2015
Isis Pharmaceuticals, Inc. - Phase III, 2015
Isis Pharmaceuticals, Inc. - Phase II, 2015
Isis Pharmaceuticals, Inc. - Phase I, 2015
Isis Pharmaceuticals, Inc. - Preclinical, 2015
Isis Pharmaceuticals, Inc. - Discovery, 2015
Isis Pharmaceuticals, Inc. - Pipeline by Target, 2015
Isis Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2015
Isis Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015
Isis Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2015
Isis Pharmaceuticals, Inc. - Recent Pipeline Updates, 2015
Isis Pharmaceuticals, Inc. - Dormant Developmental Projects,2015
Isis Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2015
Isis Pharmaceuticals, Inc., Subsidiaries
List of Figures
Isis Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2015
Isis Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
Isis Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
Isis Pharmaceuticals, Inc. - Partnered Products in Pipeline, 2015
Isis Pharmaceuticals, Inc. - Out-Licensed Products in Pipeline, 2015
Isis Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2015
Isis Pharmaceuticals, Inc. - Pipeline by Top 10 Route of Administration, 2015
Isis Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2015
Isis Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report